Bluefin Trading LLC Raises Holdings in CME Group Inc. (CME)
Bluefin Trading LLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 2.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,128 shares of the financial services provider’s stock after purchasing an additional 200 shares during the quarter. Bluefin Trading LLC’s holdings in CME Group were worth $893,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. Fiduciary Trust Co. acquired a new stake in shares of CME Group during the second quarter worth about $105,000. Parallel Advisors LLC boosted its stake in shares of CME Group by 4.1% during the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares during the period. San Francisco Sentry Investment Group CA acquired a new stake in shares of CME Group during the second quarter worth about $129,000. Whittier Trust Co. boosted its stake in shares of CME Group by 2.6% during the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after buying an additional 27 shares during the period. Finally, People s United Financial Inc. boosted its stake in shares of CME Group by 11.5% during the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after buying an additional 110 shares during the period. 82.64% of the stock is currently owned by institutional investors.
Several equities research analysts have recently weighed in on CME shares. Royal Bank Of Canada set a $130.00 target price on shares of CME Group and gave the stock a “buy” rating in a research note on Monday, June 12th. BidaskClub upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Friday, June 23rd. Deutsche Bank AG decreased their target price on shares of CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a research note on Tuesday, July 4th. Jefferies Group LLC reiterated a “buy” rating and set a $128.00 target price on shares of CME Group in a research note on Monday, July 10th. Finally, Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $134.78.
In other CME Group news, Director Dennis Suskind sold 750 shares of the company’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $129.34, for a total value of $97,005.00. Following the completion of the transaction, the director now owns 5,059 shares in the company, valued at approximately $654,331.06. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Terrence A. Duffy sold 21,815 shares of the company’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the completion of the transaction, the chairman now owns 110,711 shares of the company’s stock, valued at approximately $13,715,985.79. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,744 shares of company stock valued at $5,710,640. 0.57% of the stock is owned by insiders.
Shares of CME Group Inc. (CME) traded up 0.0923% during midday trading on Monday, reaching $137.3266. 161,616 shares of the company were exchanged. The company’s 50-day moving average price is $130.64 and its 200 day moving average price is $123.22. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $138.39. The stock has a market capitalization of $46.68 billion, a price-to-earnings ratio of 28.0316 and a beta of 0.73.
CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping the consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The firm had revenue of $925.00 million during the quarter, compared to analysts’ expectations of $931.05 million. During the same quarter in the prior year, the firm earned $1.14 EPS. CME Group’s quarterly revenue was up 2.1% on a year-over-year basis. On average, equities analysts predict that CME Group Inc. will post $4.82 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Monday, September 25th. Shareholders of record on Friday, September 8th were given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 1.92%. The ex-dividend date was Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is 53.99%.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.